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ABSTRACT 
Drug titration is the process of adjusting the dose of a medicine for the maximum benefits without adverse effects. To determine the optimum 
dose range the clinical trials are carried out and it is divided into two types of study design. The parallel type study design and titration type 
study design. The titration studies provide the information about the cumulative effects of the drug. Titration designs are mainly used in dose 
determining especially in insulin, anticonvulsants, anti-depressants, and sedatives. In the analysis of titration design, the phase I, II, III clinical 
trials are carried out to determine the dose-response relationship, safety and efficacy of the drug. 
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INTRODUCTION: 
For the development of a new drug, the dose range that 
provides the information about optimal therapeutic 
risk/benefit ratio in the targeted population to be 
determined .The clinical trials are carried out to determine 
the optimum dose range and it is divided into two types of 
study design. 
The parallel groups, fixed dose study is the first type of 
design, and it is the simplest and most commonly used 
design to learn about the dose range .In parallel group study, 
the subjects are randomly allocated to receive one set of 
fixed doses for the entire study duration. Dose adjustments 
are not allowed and the subject receives only one dose level. 
The dose titration study is the second type of design. In this 
type study, all subjects are started from the lowest set of 
dose levels. Subjects who respond on the low dose stay on 
that dose, and the other subjects who do not respond receive 
the next highest dose. This procedure is repeated until all 
subjects are drop out, respond, or reach the highest dose 
level. 
Overview: 
In the typical titration study, the response is based on some 
fixed criteria, the dose is increased with time and the subject 
may receive more than one dose level. Variations of typical 
titrations include placebo group, if the titration dose up or 
down, and a forced titration, in which all subjects receive 
higher doses despite of their responses at lower dose, and 
they do not drop for safety. 
The difference between the titration and parallel study in a 
titration study is, if a subject fails to respond at a lower dose 
they receives the next higher dose, the target populations 
are different at each titration step. For example, in a parallel 
study the target population for subjects who receive dose 
level 2 is all subjects who have the disease. In a titration  
study, the target populations for subjects who receive the 
dose level 2 have the disease but failed to respond for the 
lower dose level 1.For titration study the target populations  
at dose level 2 are different in each study. This is the reason 
for the responders at a particular dose level in a parallel 
study should not be compared directly with the responders 
at that same level in a titration study. The analysis and 
interpretation of a titration study is more complicated than 
the parallel study. [1, 2]    
Uses of Titration Designs  
Clinical Rationale: 
In a titration study, the subjects are exposed to the amount 
of drug necessary to control their disease. This is the good 
clinical practice and is the main reason to titrate the dose. 
The titration studies provides the information on the 
sequential and cumulative effects of the drug, so they are 
used in clinical trials with drugs intended for long term use 
at varying dose levels such as antihypertensive drugs. 
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Titration designs are used for diabetic subjects in evaluating 
formulations of insulin, because it is usually necessary that 
dose for each individual subject should be titrated up or 
down until the desired response is reached.  
Even if titration appears to be appropriate for clinical 
reasons, the following requirements are necessary for the 
appropriate use of titration study. 
 The response to the titration must be well-defined and 
easily measurable.[3] 
 The number of dropout cannot be excessive. [3] 
 The cumulative effect of the drug must be nominal. [3] 
 If the response is irreversible, such as cure of a 
bacterial infection, then the use of a titration design is 
not appropriate.[1,3] 
 Titrations design’s may not be suitable in diseases such 
as ceteoporosis, Alzheimer’s disease, or depression 
because the desired response takes long period of time 
if the treatment is extended it may be difficult to 
measure. 
Disadvantages of Titration: 
 During the course of treatment the disease may 
progress, the subjects may exhibit spontaneous 
improvement, or the drug may have some cumulative 
effects. 
 One of the important issues in a titration study is 
deciding when to titrate the dose. If the dose is titrated 
upwards before its full effect is realized, the subject 
exposed to high dose level and the recommended is 
overestimated. 
 With some drugs the carryover effect may exist from 
one dosing period to another, because in titration 
study the doses are given in increasing order, this 
carryover effect maybe harder to estimate compared to 
other types of designs. 
Advantages of Titration: 
 Titrations designs provide both practical and statistical 
advantages. 
 The main practical advantages of titration designs are 
in compliance with good clinical practice, and the 
subjects are exposed only to the required amount of 
the drug to control their disease, and in the same dose 
the drug will be prescribed . 
 The statistical advantage is that each subject may 
receive more than one dose, titration design provide 
information on the distribution of individual dose 
response curves and population average dose response 
curve. 
 Another statistical advantage is that titration studies 
can be used to examine the response over a wide range 
of doses, with smaller number of subjects than a 
parallel study with same statistical power. 
 Sheiner et al stated that titration study can be more 
advantageous than the parallel or cross over study, if a 
patient specific parameter dose response model is 
used, based on comparison between the crossover, 
parallel, and titration designs in dose ranging studies. 
 Titration designs are useful in phase I tolerance trials, 
the goal is to assess the safety of the drug. In early 
phase I/II exploratory studies, when the drug is 
assumed to have an effect but little is known about 
dose response relationship.[1,4] 
 The goal of these studies is to examine the 
effectiveness of the drug over a wide range of doses to 
define the shape of the dose response curve.  
 The benefit in this phase III studies is the subjects are 
more closely similar to the target population of 
subjects with the disease. With the incorporation of a 
placebo group and appropriate analysis and it provides 
pieces of evidence of the safety and overall efficacy of 
the drug and effectiveness of the various doses.[5] 
Analysis of a Titration Design: 
Types of Analysis 
Life Table Approach: [1] 
Based on the analysis of a titration study three general 
assumptions are made. 
1. During the period, one dose which is administered is long 
enough for the physiological systems to stabilize. 
2. Subject who responds at one dose will respond at all 
higher doses. 
3. The number of subjects who receive a particular dose, the 
number of responders at that dose follows a binomial 
distribution. 
Incomplete Design Approach: 
In a complete design, all subjects are exposed to all dose 
levels. In incomplete design all subjects are not exposing to 
all dose levels. The assumption is that a subject who 
responds at one dose may not at all higher doses in the 
incomplete design approach.  
Contingency Table Approach: 
In phase I/II clinical trials the dose-response relationship is 
established. In phase III clinical trials, efficacy and safety are 
confirmed. A phase III clinical trials can be used to 
determine, the starting dose which is therapeutically useful, 
based on overall response rate and a maximally effective 
dose is reached whether it titrates to the low or high dose. 
Titration with Placebo Controls: 
If a placebo effect is expected to be high the magnitude of the 
effect and efficacy of the drug can be estimated by the 
insertion of the placebo control group (it contains all the 
excipients except drug). The effect of the dose can be 
measured by including the placebo controls for that dosing 
group. 
Analysis of Safety Data: 
The analysis of safety data in a titration study presents 
special problems, and the estimation of the risky/benefit 
ratio is challenging, even the response is easily measurable 
and occurs in a short period of time. The incidence of the 
adverse effects depends upon the amount of the dose given 
to the subject.  
The assumption is that analyzing the safety data in titration 
study is different for analyzing the efficacy data. The 
assumption is that analysis of efficacy data in a titration 
study is that a subject who responds at lower doses will 
respond at all higher dose levels. If a subject experiences an 
adverse effect at one dose level and it is not necessary that 
subject would have same adverse effects at higher dose 
levels. 
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CONCLUSION: 
Parallel and titrations studies are used in dose finding and 
comparative studies. Parallel studies are useful in 
determining the effectiveness of various doses through the 
use of independent dose groups having the same duration of 
treatment and fixe dose, short term prescriptions. Titrations 
studies provide information about the sequential and 
cumulative effects of the drug at various dose levels, and 
used for long term prescriptions. [5] 
The titration designs can provide information on the safety 
and efficacy of the drug. By including a placebo group and 
taking into account the dose, speed, and time of the titration, 
and the titration design, it can provide the information about 
the effect by dose, but the result is different for each subject 
with variation of time.   
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